"The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has a limited commercial operating history and may not be able to comply with certain debt covenants, which raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also
described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty."
So my prediction: New shelf registration this summer, reverse split and new massively dilutive stock offering by fall. I've seen this spiral before - the only ones who continue to profit through it are management - so it's your money to lose, but don't say I didn't warn ya. I'm outta here - good luck!
Was this the first report you have ever read. .? These statements are in every small cap pharmaceutical report. If these "gems" as you call them made you sell. .. well its good that you are out, and stay out of the market its better for you.